Yahoo
Shanghai - Delayed Quote CNY

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)

22.00 +2.00 (+10.00%)
At close: October 30 at 3:00:01 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
3,951,983.54
3,853,391.13
3,500,831.29
3,311,472.61
3,001,862.21
Cost of Revenue
850,338.32
769,552.15
846,562.05
884,387.42
832,113.81
Gross Profit
3,101,645.22
3,083,838.98
2,654,269.24
2,427,085.18
2,169,748.40
Operating Expense
2,191,431.51
2,245,380.70
1,896,847.70
1,817,406.16
1,740,135.99
Operating Income
910,213.71
838,458.28
757,421.54
609,679.02
429,612.41
Net Non Operating Interest Income Expense
9,730.64
5,102.38
18,885.23
35,128.56
26,587.45
Pretax Income
961,302.22
879,465.63
827,573
653,044.17
517,034.53
Tax Provision
129,005.12
117,017.78
104,988.30
84,928.47
51,729.56
Net Income Common Stockholders
827,369.85
759,503.03
722,550.72
568,109.30
465,304.59
Basic EPS
1.46
1.34
1.29
1.01
0.84
Diluted EPS
1.46
1.34
1.28
1.00
0.82
Basic Average Shares
566,354.81
566,793.31
561,422.47
561,372.83
556,584.44
Diluted Average Shares
567,094.50
567,640.53
564,052.08
566,410.07
568,137.48
Total Operating Income as Reported
969,668.98
887,273.91
810,301.68
656,307.24
517,121.48
Total Expenses
3,041,769.83
3,014,932.85
2,743,409.75
2,701,793.59
2,572,249.80
Net Income from Continuing & Discontinued Operation
827,369.85
759,503.03
722,550.72
568,109.30
465,304.59
Normalized Income
824,878.41
764,939.41
727,980.96
575,631.19
463,265.30
Interest Income
12,975.24
9,728.11
18,824.72
35,717.96
27,952.06
Interest Expense
2,661.46
3,900.52
-767.49
-179.79
774.62
Net Interest Income
9,730.64
5,102.38
18,885.23
35,128.56
26,587.45
EBIT
963,963.68
883,366.15
826,805.50
652,864.38
517,809.15
EBITDA
963,963.68
981,941.79
900,349.56
730,488.71
594,058.63
Reconciled Cost of Revenue
850,338.32
769,552.15
846,562.05
884,387.42
832,113.81
Reconciled Depreciation
83,153.45
98,575.64
73,544.05
77,624.34
76,249.48
Net Income from Continuing Operation Net Minority Interest
827,369.85
759,503.03
722,550.72
568,109.30
465,304.59
Total Unusual Items Excluding Goodwill
2,877.61
-6,270.74
-6,219.23
-8,646.34
2,266.01
Total Unusual Items
2,877.61
-6,270.74
-6,219.23
-8,646.34
2,266.01
Normalized EBITDA
961,086.07
988,212.53
906,568.78
739,135.06
591,792.62
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
386.17
-834.36
-788.99
-1,124.46
226.72
12/31/2022 - 10/18/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: